Skip to content

The effect of cupping method in the treatment of menorrhagia

Comparing the efficacy of cupping method and medroxyprogesterone acetate in reducing menstrual bleeding in women with heavy menstrual bleeding

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016052528080N1
Enrollment
162
Registered
2016-06-25
Start date
2015-11-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DUB. Excessive, frequent and irregular menstruation

Interventions

Intervention 1: control group: patients will receive one tablet of 10 mg of medroxyprogesterone acetate, daily, during the luteal phase for three menstrual cycles. Intervention 2: The intervention gro
Treatment - Drugs
Treatment - Devices
control group: patients will receive one tablet of 10 mg of medroxyprogesterone acetate, daily, during the luteal phase for three menstrual cycles
The intervention group is treated with cupping in the six symmetrical points on the chest for ten minutes each times and for three times every day , between two course of cupping, 30 minutes rest ti

Sponsors

Tehran university of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women with uterine bleeding disorders; Patients referred by a gynecologist with disorders of uterine bleeding; patient with completed informed consent form Exclusion criteria: women younger than 20 or older than 50 years; history of chest surgery in the last three months; active systemic infection disease; active infected edema on Skin or injury on cupping site; coagulation disorders; use of bleeding-lowering drugs such as Mefenamic acid, etc. during the study period; uterine fibrosis with endometrial thickness; fraction in the chest area ,especially in the ribs 7-12 on cupping site; chemical medicines or herbal and other alternative medicine methods used during the study; pregnant or plan to become pregnant during the study; dependence on drugs in the past 6 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Patient’s score of bleeding. Timepoint: the first menstrual cycle as well as one and three months after the intervention. Method of measurement: Pictorial Assessment of Blood Loss questionnaire.

Secondary

MeasureTime frame
Menorrhagia quality of life questionnaire. Timepoint: 1 month. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Azizkhani

Tehran University of Medical SCiences

Dr_mo_Azizkhani@yahoo.com+98 21 7790 9020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026